RATINGS CHANGES

American International(AIG) - Get Report was downgraded from hold to sell, Deutsche Bank said. The stock has a $61 price target. The loss of Peter Hancock is a negative.

Amrep (AXR) - Get Reportwas downgraded to sell at TheStreet Ratings. You can view the full analysis from the report here: AXR.

Boeing(BA) - Get Report was downgraded from overweight to equal-weight, Morgan Stanley said. The stock has a $190 price target. This was a valuation call, as the stock is up 15% year-to-date.

Bioverativ (BIVV) was downgraded from buy to neutral, Goldman Sachs said. It has a $55 price target. The company is facing increased competition.

Blueprint Medicines(BPMC) - Get Report was upgraded from neutral to buy, Goldman Sachs said. It has a $52 price target. The company has strong pipeline momentum.

Boardwalk Pipeline Partners (BWP) was upgraded to buy at TheStreet Ratings.You can view the full analysis from the report here: BWP.

Rockwell Collins (COL) was upgraded to overweight, Morgan Stanley said. It has a $121 price target. The BEAV acquisition could add as much as 30% to earnings.

Gartner(IT) - Get Report was upgraded to top pick, Goldman Sachs said. It has a $124 price target. The CEB acquisition can drive growth over the next several quarters.

Johnson Controls(JCI) - Get Report was downgraded from buy to neutral, Goldman Sachs said. It has a $44 price target. Analysts see a limited downside to synergy targets.

The New York Times (NYT) - Get Report was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: NYT

This article was written by a staff member of TheStreet.